| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total assets | 8,584 | 7,788 | ||
| Total liabilities | 3,141 | 3,255 | ||
| Common stock, 0.001 par value - 150,000,000 shares authorized as of september 30, 2025 and december 31, 2024 1,367,429 and 1,364,940 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 65 | - | ||
| Additional paid-in capital | 285,259 | - | ||
| Accumulated deficit | -279,881 | - | ||
| Total stockholders' equity | 5,443 | 4,533 | ||
| Total liabilities and stockholders equity | 8,584 | 7,788 | ||
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)